1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)


Table 2: 
CSF markers and APOE status in the MCI groups
MCI Sample 1MCI Sample 2P
NN
Aβ42 (pathologic/not pathologic)3/143/16.89
Tau (pathologic/not pathologic)7/106/13.56
Any CSF pathologic features (pathologic/not pathologic)8/97/12.55
APOE ε4 alleles (0/1/2)8/6/410/6/3.58
  • Note:—MCI indicates mild cognitive impairment; Aβ42, amyloid beta 42 peptide; APOE ε4, apolipoprotein E.
  • P denotes the P values from an independent samples t test.